Metformin is one of the first-line therapies for Type 2 diabetes, as it helps improve insulin sensitivity and reduces glucose production in the liver
Store between -10C to -25C( -13F to -14F) 647-233-1202 [email protected] 3281 Aubrey Rd, Mississauga, Ontario L5L 5C9 Canada
A., Novotny, E
However, based on the clinical trial criteria used in studies such as the Phase 2 trial published in the New England Journal of Medicine (2023), researchers have investigated its use in adults with: Obesity , defined as a body mass index (BMI) of 30 kg/m or above Overweight (BMI 27 kg/m or above) with at least one weight-related comorbidity, such as hypertension, dyslipidaemia, or obstructive sleep apnoea Type 2 diabetes , where improved glycaemic control alongside weight reduction is a treatment goal In clinical trials, participants were typically adults without a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2)
Without the drugs in your system, you will likely have an increased appetite that may cause you to eat more and regain some of the weight you lost